Neoss® was founded in 2000, with the objective of ”Advancing the Science of Dental Implant Treatment”, by Fredrik Engman, Neoss Chief Technology Officer, and Professor Neil Meredith. Neoss Head Office was established and remains in Harrogate, North Yorkshire, United Kingdom. In 2006 Neoss established a Research and Product Development centre in Göteborg (Gothenburg), Sweden.
Since this time Neoss has continued to innovate and invest in Research and Product Development, designing, manufacturing and selling products of the highest quality which offer market leading functionality. Neoss Implants, manufactured in Sweden, are protected by a number of significant patents including patents covering the NeoLoc® Implant-Abutment connection and the Neoss ProActive® surface which can be found on all current Neoss Implants as signified by the name’s ProActive Straight Implant and ProActive Tapered Implant.
Neoss original Bimodal Implant was, in 2009, enhanced with the addition of the ProActive®surface when the company launched the Neoss ProActive® Straight implant, which is a superhydrophilic implant. The ProActive surface enhances protein aggregation and can accelerate fibrin network formation. Studies show that the ProActive implant surface stimulates bone to form more rapidly and with a greater strength at the implant interface. In 2012 Neoss introduced the new Neoss ProActive® Tapered implant, which uses the same surface technology.
In addition to the ProActive surface Neoss Straight and Tapered Implants benefit from the ‘Thread Cutting and Forming’ design providing high initial stability, ‘One abutment connection’ (excluding Ø3.25) providing great prosthetic freedom and a surgical kit with a minimal number of components.
In 2015 Neoss introduced the NeoGen® titanium reinforced PTFE membrane. This new generation of non-resorbable titanium-reinforced membrane combines the handling and tissue interactions of expanded PTFE with the enhanced barrier function offered by dense PTFE. The membrane has a three-layer design. The outer, soft tissue friendly, PTFE layer has a tight texture that is designed to resist bacteria permeability; the middle layer is a strong and highly shapeable titanium mesh; and the inner PTFE layer has an expanded texture that enables predictable hard tissue integration. This combination results in a membrane that is easy to handle and protects the augmentation site in a predictable manner.
Neoss continues to carry out innovate, carrying out research and product development to improve the treatment of patients the world over.